L-Glutamic acid,N-[4-[[(2-amino-3,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-

Independent reference data for L-Glutamic acid,N-[4-[[(2-amino-3,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl)methyl]amino]benzoyl]- (CAS 31690-09-2), compiled from public chemistry databases.

Registry identifiers across databases

Computed descriptors

Physicochemical values on record

Documented uses on record

For the treatment and prevention of folate deficiency and for use as an antidote against folic acid antagonists. Contained in oral contraceptives to reduce the risk of neural tube defects arising from folic acid deficiency for pregnant women who conceived during use or shortly after the discontinuation of the product. Being studied for use as a treatment for cardiovascular diseases and adjunct therapy for patients undergoing antidepressant pharmacotherapy.Take with or without food. Recommendations vary from product to product - consult individual product monographs for additional information.

Synonyms and trade names

Levomefolic acid; 31690-09-2; Levomefolinic acid; LMSR; L-methylfolate; L-5-MTHF; Nutrifolin; 8S95DH25XC; Acido levomefolico; 5-methyl-(6s)-tetrahydrofolic acid; Acide levomefolique; DTXSID00185583; L-methyl folate; acidum levomefolicum; L-methyltetrahydrofolate; RefChem:799024

What the public record says

L-Glutamic acid,N-[4-[[(2-amino-3,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl)methyl]amino]benzoyl]- · CAS 31690-09-2 · C20H25N7O6. UNII 8S95DH25XC. Boiling Point: 221; Collision Cross Section: 197.3 Ų [M+H]+; Collision Cross Section: 199.8 Ų [M-H]-.

Physical description and handling notes

Source: PubChem / Wikidata; the batch COA governs where values differ.